Results 51 to 60 of about 18,891 (189)

Trimethylamine-N-oxide is an independent risk factor for hospitalization events in patients receiving maintenance hemodialysis

open access: yesRenal Failure, 2020
Background Hospitalization is a significant outcome measurement for maintenance hemodialysis pantients. Trimethylamine-N-oxide (TMAO), created by gut microflora from dietary l-carnitine and choline, cleared by the kidney, has been implicated in the ...
Yin Zheng   +5 more
doaj   +1 more source

A Multi-omic Association Study of Trimethylamine N-Oxide [PDF]

open access: yesCell Reports, 2018
Trimethylamine N-oxide (TMAO) is a circulating metabolite that has been implicated in the development of atherosclerosis and cardiovascular disease (CVD). In this paper, we identify blood markers, metabolites, proteins, gut microbiota patterns, and diets that are significantly associated with levels of plasma TMAO.
Ohad, Manor   +7 more
openaire   +2 more sources

Trimethylamine N‐Oxide and Mortality Risk in Patients With Peripheral Artery Disease

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2016
BackgroundProduction of the proatherogenic metabolite, trimethylamine N‐oxide (TMAO), from dietary nutrients by intestinal microbiota enhances atherosclerosis development in animal models and is associated with atherosclerotic coronary artery disease in ...
Vichai Senthong   +5 more
doaj   +1 more source

Circulating metabolites from the choline pathway and acute coronary syndromes in a Chinese case-control study

open access: yesNutrition & Metabolism, 2020
Background Accumulating evidence shows that circulating levels of trimethylamine N-oxide, which is generated from the metabolism of dietary choline, may predict cardiovascular disease among Caucasians.
Yuxiang Dai   +12 more
doaj   +1 more source

The food-derived metabolite trimethylamine and trimethylamine-N-oxide promote colorectal cancer progression via SREBF1

open access: yesEcotoxicology and Environmental Safety
Colorectal cancer (CRC) is characterised by microbial dysbiosis. Trimethylamine (TMA) and trimethylamine-N-oxide (TMAO) are gut microbiota-derived metabolites produced from dietary precursors that are implicated in CRC progression.
Yang Yan   +12 more
doaj   +1 more source

Restored mutant receptor:Corticoid binding in chaperone complexes by trimethylamine N-oxide. [PDF]

open access: yesPLoS ONE, 2017
Without a glucocorticoid (GC) ligand, the transcription factor glucocorticoid receptor (GR) is largely cytoplasmic, with its GC-binding domain held in high affinity conformation by a cluster of chaperones.
Aaron L Miller   +5 more
doaj   +1 more source

Trimethylamine-N-Oxide

open access: yesJACC: Basic to Translational Science, 2021
Fadi W. Adel, Horng H. Chen
openaire   +1 more source

Gut Microbe-Generated Metabolite Trimethylamine-N-Oxide and Ischemic Stroke

open access: yesBiomolecules
Trimethylamine-N-oxide (TMAO) is a gut microbiota-derived metabolite, the production of which in vivo is mainly regulated by dietary choices, gut microbiota, and the hepatic enzyme flavin monooxygenase (FMO), while its elimination occurs via the kidneys.
Zhen Li, Xinyi He, Qi Fang, Xulong Yin
doaj   +1 more source

Trimethylamine N-Oxide Exacerbates Cardiac Fibrosis via Activating the NLRP3 Inflammasome

open access: yesFrontiers in Physiology, 2019
Background/Aims: Gut microbiota has been reported to correlate with a higher mortality and worse prognosis of cardiovascular diseases. Trimethylamine N-oxide (TMAO) is a gut microbiota-dependent metabolite of specific dietary nutrients, which is linked ...
Xueling Li   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy